Last update 23 Jun 2026

Beijing Kejing Biotechnology Corp.

Subsidiary Company|2021|Beijing Shi, China

Overview

Tags

Neoplasms
Cardiovascular Diseases
Hemic and Lymphatic Diseases
CAR-NK
Natural Killer Cell Therapies

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms2
Hemic and Lymphatic Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
CAR-NK2
Natural Killer Cell Therapies1

Related

3
Drugs associated with Beijing Kejing Biotechnology Corp.
XTS01
Target-
Mechanism-
Active Org.
Beijing Kejing Biotechnology Corp.
Originator Org.
Beijing Kejing Biotechnology Corp.
Active Indication
Ovarian Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
XTCV1
Target-
Mechanism-
Active Org.
Beijing Kejing Biotechnology Corp.
Originator Org.
Beijing Kejing Biotechnology Corp.
Active Indication
Cardiovascular Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
XT033
Target-
Mechanism-
Active Org.
Beijing Kejing Biotechnology Corp.
Originator Org.
Beijing Kejing Biotechnology Corp.
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Beijing Kejing Biotechnology Corp.
NCT06284226
/ WithdrawnEarly Phase 1
An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients
100 Clinical Results associated with Beijing Kejing Biotechnology Corp.
Login to view more data
0 Patents (Medical) associated with Beijing Kejing Biotechnology Corp.
Login to view more data
100 Deals associated with Beijing Kejing Biotechnology Corp.
Login to view more data
100 Translational Medicine associated with Beijing Kejing Biotechnology Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
XT033
Acute Myeloid Leukemia
More
Preclinical
XTS01
Ovarian Cancer
More
Preclinical
XTCV1
Cardiovascular Diseases
More
Preclinical
Allogeneic NK(Escure Biotechnology)
Malignant Solid Neoplasm
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free